| Literature DB >> 17907380 |
Samira Benzaria1, Dorothée Bardiot, Tony Bouisset, Clément Counor, Céline Rabeson, Claire Pierra, Richard Storer, Anna Giulia Loi, Alessandra Cadeddu, Massimo Mura, Chiara Musiu, Michel Liuzzi, Roberta Loddo, Svetlana Bergelson, Vadim Bichko, Edward Bridges, Erika Cretton-Scott, John Mao, Jean-Pierre Sommadossi, Maria Seifer, David Standring, Michele Tausek, Gilles Gosselin, Paolo La Colla.
Abstract
RNA viruses are the agents of numerous widespread and often severe diseases. Their unique RNA-dependent RNA polymerase (RDRP) is essential for replication and, thus, constitutes a valid target for the development of selective chemotherapeutic agents. In this regard, we have investigated sugar-modified ribonucleoside analogues as potential inhibitors of the RDRP. Title compounds retain 'natural' pyrimidine bases, but possess a beta-methyl substituent at the 2'-position of the D- or L-ribose moiety. Evaluation against a broad range of RNA viruses, either single-stranded positive (ssRNA+), single-stranded negative (ssRNA-) or double-stranded (dsRNA), revealed potent activities for D-2'-C-methyl-cytidine and -uridine against ssRNA+, and dsRNA viruses. None of the L-enantiomers were active. Moreover, the 5'-triphosphates of the active D-enantiomers were found to inhibit the bovine virus diarrhoea virus polymerase. Thus, the 2'-methyl branching of natural pyrimidine ribonucleosides transforms physiological molecules into potent, broad-spectrum antiviral agents that merit further development.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17907380 DOI: 10.1177/095632020701800406
Source DB: PubMed Journal: Antivir Chem Chemother ISSN: 0956-3202